Production of Meta-Iodobenzilguanidine, ¹²³I Preparation for Medical Diagnostics

Abstract:

This paper demonstrates a method for production of the radiopharmaceutical meta-iodobenzilguanidin (MIBG) labeled with radionuclide iodine-123 (123I). An experimental installation has been developed and the conditions of solid-phase synthesis of the preparation have been described. The influence of the content of ammonium sulfate in the reaction mixture and the temperature and duration of dry synthesis on the process of labeling has been researched. It has been established experimentally that when the ratio of MIBG and ammonium sulfate is 1:4, it is efficient to carry out synthesis at the temperature of 150°C to rapidly obtain a preparation with radiochemical purity of over 97%. Biomedical tests of the synthesized preparation have been carried out in experimental animals. Its functional suitability for scintigraphic studies has been shown.

• Periodical: Advanced Materials Research (Volume 1084)
• Pages: 451-455
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.1084.451
• Online since: January 2015
• Authors: Ilyas E. Slamkulov, Viktor S. Skuridin, Aleksey S. Semenov, Aleksandr A. Garapatsky
• Keywords: Iodine-123, Meta-Iodobenzilguanidine, MIBG, Radiopharmaceutical

References

[1] A.R. Wafelman, C.A. Hoefnagel, J.H. Beijnen, Chromatographic determination of the radiochemical purity of [131I]MIBG infusion fluids: a comparison and discussion of the chromatographic characteristics using three different techniques, J. Applied Radiation and Isotopes 44 (1993).

DOI: 10.1016/0969-8043(93)90029-a

[2] W.H. Bierwalters, Radioiodine therapy of thyroid disease, J. Nucl. Med. Biol. 14 (1987) 183-185.

[3] G. Vaidyanathan, M.R. Zalutsky, No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue, J. Appl. Radiat. Isot. 44 (1993) 621-623.

DOI: 10.1016/0969-8043(93)90179-e

[4] T. Yassin, M. Bakir, Preparation, purification and quality control of 131I-m-iodobenzyl-guanidine (MIBG)*, J. Radioanalytic. Nucl. Chem. 3 (2003) 635-637.

[5] A. Katsifis, V. Parazian, A rapid and efficient preparation of [123I] radiopharmaceuticals using a small HPLC (Rocket) column , J. Appl. Radiat. Isot. 64 (2006) 27-31.

DOI: 10.1016/j.apradiso.2005.06.006

[6] R. Mastrangelo, S. Tornesello, 131I-metaiodobenzylguanidine in the treatment of neuroblastoma, J. Med. Pediatr. Oncol. 31 (1998) 22-24.

DOI: 10.1002/(sici)1096-911x(199807)31:1<22::aid-mpo5>3.0.co;2-1

[7] G. Vaidyanathan, M. Zalutsky, No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation, J. Nucl. Med. Biol. 22 (1995) 61-64.

DOI: 10.1016/0969-8051(94)00078-x

[8] A. Donovan, J. Valliant, A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity, J. Nucl. Med. Biol. 35 (2008) 741-744.

DOI: 10.1016/j.nucmedbio.2008.07.006

[9] A. Donovan, J. Forbes, P. Dorff, P. Schaffer, J. Babich, J.F. Valliant, A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports , J. Am. Chem. Soc. 128 (2006) 36-40.

DOI: 10.1021/ja0600375

[10] V.S. Scuridin, Methods and technology for radiopharmaceuticals preparation: tutorial, Tomsk Polytechnic University, Tomsk, Publishing house of TPU, 2012 (in Russian).

[11] A.S. Semenov, V.S. Skuridin, V.M. Golovkov, The preparation radiopharmaceutical meta-iodobenzilguanidine radioiodinated, J. Izvestia Vyshich Uchebnych Zavedeniy. Fizika. 54 (2011) 310-314 (in Russian).

[12] A.A. Garapatski, V.Y. Kаsakov, N.V. Thien, The Gamma-Ray Scanner of a Chromatographic Plate for Determining the Radiochemical Purity of Radiopharmaceuticals, In Proc. of the 7th International Forum on Strategic Technology (IFOST). 2 (2012).

DOI: 10.1109/ifost.2012.6357818